Product Pipeline

The Silent Crisis in Joint Health: Osteoarthritis is the leading cause of chronic pain in dogs, affecting 20% of all adults and 80% of seniors. With mobility loss driving nearly 50% of owner-elected euthanasia, the "slow down" we see is actually a urgent medical emergency.

Our Solution: We are developing a precision protein therapeutic designed to go beyond surface-level pain relief. By targeting the biological drivers of inflammation at the molecular level, we aim to halt joint degradation and restore the quality of life.

Cost-effective Growth Factors: The primary barrier to scaling cultivated meat is the cost of growth factors, which currently account for up to 90% of total production expenses. To replace conventional meat, the industry must reduce the cost of these essential proteins by over 1,000x to achieve price parity at the grocery store.

Our Solution: We are developing optimized recombinant growth factors specifically engineered for large-scale food production and for other applications.